Recently identified recurrent alterations in DNM2 (17%), PHF6 (11%), DNMT3A (5%) or RELN (5%) were confirmed in this larger cohort of adult T-ALL patients[20,21,27] (Table 2). This evidence concerns the gene DNM2 and acute lymphoblastic leukemia.